LANTHEUS Aktie

>LANTHEUS Aktienkurs

45 EUR -4.0% (Tradegate)

Ask: 45.24 EUR / 670 Stück

Bid: 44.97 EUR / 670 Stück

Tagesumsatz: 2286 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

LANTHEUS Aktie über LYNX handeln

Intraday

1 Jahr

>LANTHEUS Performance

1 Woche: -4,5%

1 Monat: -1,9%

3 Monate: -35,6%

6 Monate: -50,7%

1 Jahr: -52,3%

laufendes Jahr: -48,4%

>LANTHEUS Aktie

Name:

LANTHEUS HLDGS DL-,01

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US5165441032 / A117UE

Symbol/ Ticker:

0L8 (Frankfurt) / LNTH (NASDAQ)

Kürzel:

FRA:0L8, ETR:0L8, 0L8:GR, NASDAQ:LNTH

Index:

Webseite:

Profil:

Lantheus Holdings, Inc. is a leading healthcare co..
>Volltext..

Marktkapitalisierung:

3067.73 Mio. EUR

Unternehmenswert:

2999.75 Mio. EUR

Umsatz:

1295.96 Mio. EUR

EBITDA:

421.1 Mio. EUR

Nettogewinn:

230.96 Mio. EUR

Gewinn je Aktie:

3.35 EUR

Schulden:

524.55 Mio. EUR

Liquide Mittel:

592.79 Mio. EUR

Operativer Cashflow:

447.54 Mio. EUR

Bargeldquote:

2.48

Umsatzwachstum:

-3.85%

Gewinnwachstum:

-42.49%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

3 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 382.591.304 USD.

Suchwörter:

LANTHEUS

Letzte Datenerhebung:

14.09.25

>LANTHEUS Kennzahlen

Aktien/ Unternehmen:

Aktien: 67.99 Mio. St.

Frei handelbar: 97.77%

Leerverk. Aktien: 10.83%

Rückkaufquote: 5.26%

Mitarbeiter: 808

Umsatz/Mitarb.: 1.62 Mio. EUR

Analysten:

Analystenrating: Strong buy

Kursziel: 70.28%

Bewertung:

KGV: 14.05

KGV lG: 9.23

KUV: 2.51

KBV: 3.08

PEG-Ratio: -

EV/EBITDA: 7.12

Rentabilität:

Bruttomarge: 63.75%

Gewinnmarge: 17.82%

Operative Marge: 28.47%

Managementeffizenz:

Gesamtkaprendite: 13.36%

Eigenkaprendite: 24.71%

>LANTHEUS Peer Group

Es sind 601 Aktien bekannt.

>LANTHEUS Chart & Kurs - NASDAQ

>LANTHEUS News

14.09.25 - 18:03	LNTH INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Lantheus Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit (PR Newswire)
	NEW YORK, Sept. 14, 2025 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Lantheus Holdings, Inc. ("Lantheus" or "the Company") (NASDAQ: LNTH) and certain of......

14.09.25 - 14:33	SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus (PR Newswire)
	Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Lantheus To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Lantheus between February 26, 2025 and August 5, 2025......

12.09.25 - 04:27	INVESTIGATION ALERT: Edelson Lechtzin LLP Announces An Investigation Of Lantheus Holdings, Inc. (NASDAQ: LNTH) and Encourages Investors with Substantial Losses to Contact the Firm (PR Newswire)
	NEWTOWN, Pa., Sept. 11, 2025 /PRNewswire/ -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Lantheus Holdings, Inc. ("Lantheus") (NASDAQ: LNTH), resulting from allegations of providing potentially misleading business information to the......

11.09.25 - 19:51	LNTH Investors with Losses in Excess of $100K Have Opportunity to Lead Lantheus Holdings, Inc. Securities Fraud Lawsuit (PR Newswire)
	NEW YORK, Sept. 11, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Lantheus Holdings, Inc. (NASDAQ: LNTH) between February 26, 2025 and August 5, 2025, both dates......

11.09.25 - 03:48	LNTH INVESTOR ALERT: Lantheus Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead the Lantheus Class Action Lawsuit (PR Newswire)
	SAN DIEGO, Sept. 10, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Lantheus Holdings, Inc. (NASDAQ: LNTH) securities between February 26, 2025 and August 5, 2025, inclusive (the "Class Period"), have until November 10, 2025 to seek......

11.09.25 - 00:06	LNTH Financial Loss? Robbins LLP Informs Investors of the Lantheus Holdings, Inc. Class Action Lawsuit (PR Newswire)
	SAN DIEGO, Sept. 10, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Lantheus Holdings, Inc. (NASAQ: LNTH) securities between February 26, 2025 and August 5, 2025. Lantheus is a......

08.09.25 - 21:33	INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lantheus Holdings, Inc. - LNTH (PR Newswire)
	NEW YORK, Sept. 8, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The......

04.09.25 - 02:57	LNTH Investors Have Opportunity to Join Lantheus Holdings, Inc. Fraud Investigation with the Schall Law Firm (PR Newswire)
	LOS ANGELES, Sept. 3, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Lantheus Holdings, Inc. ("Lantheus" or "the Company") (NASDAQ: LNTH) for violations of the securities laws.......

27.08.25 - 16:01	INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lantheus Holdings, Inc. - LNTH (PR Newswire)
	NEW YORK, Aug. 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The......

22.08.25 - 01:01	Insiderhandel: Insider verkauft Aktien von Lantheus Holdings im Wert von 2268940 USD (Insiderkauf)
	Patel, Rajiv A. - Sonstiges / enge Beziehung - Tag der Transaktion: 2025-08-19...

22.08.25 - 01:01	Insiderhandel: Insider verkauft Aktien von Lantheus Holdings im Wert von 188944750 USD (Insiderkauf)
	Patel, Rajiv A. - Sonstiges / enge Beziehung - Tag der Transaktion: 2025-08-20...

20.08.25 - 20:01	Life Molecular Imaging Expands Neuraceq® (florbetaben F-18 injection) Production in Southern California (PR Newswire)
	Unlocking a new geography, making Neuraceq® available to more patients BOSTON, Aug. 20, 2025 /PRNewswire/ -- Life Molecular Imaging (LMI), a Lantheus company, dedicated to developing and offering novel PET radiopharmaceuticals, has expanded its manufacturing and distribution network for......

16.08.25 - 02:01	Insiderhandel: President verkauft Aktien von Lantheus Holdings im Wert von 163924 USD (Insiderkauf)
	Blanchfield, Paul - Vorstand - Tag der Transaktion: 2025-08-13...

12.08.25 - 21:27	Lantheus drops as Truist downgrades after Q2 miss (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

07.08.25 - 03:15	Lantheus lowers 2025 revenue and EPS outlook, targets $1.475B–$1.51B revenue as pricing pressures persist (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

06.08.25 - 21:36	Lantheus (LNTH) Q2 Revenue Falls 4% (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

06.08.25 - 13:42	Lantheus announces FDA review for new radioactive imaging agent (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

06.08.25 - 12:48	Lantheus Announces FDA Acceptance of NDA for New Formulation for Market-Leading PSMA PET Imaging Agent (GlobeNewswire EN)
	Designed to expand PSMA PET imaging access for patients by increasing batch size by ~50% and enhancing supply resiliencePDUFA date set for March 6, 2026...

05.08.25 - 18:51	Lantheus Holdings Q2 2025 Earnings Preview (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

22.07.25 - 13:03

Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D (GlobeNewswire EN)

BEDFORD, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH), today announced the successful completion of its previously disclosed acquisition of Life Molecular Imaging Ltd. ("Life Molecular"), a subsidiary of Life Healthcare Group Holdings Ltd ("Life Healthcare"). As part of the acquisition, Ludger Dinkelborg, PhD, formerly CEO and Managing Director of Life Molecular Imaging, has been appointed Head of Research and Development at Lantheus effective August 1, 2025....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Wenn eine Frau einen Fehltritt begeht, schiebt sie die Schuld auf die Schuhe, die der Mann ihr gekauft hat. - Louis Bultel

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram